Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 8/20 | 0.45 |
| ▸ | GGPS1 | O95749 | 5/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | PPARD | Q03181 | 3/20 | 0.43 |
| ▸ | PPARA | Q07869 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | FABP4 | P15090 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8380652 | 1.00 | FDPS (0.45) | FDPSGGPS1CES2GAAPPARG | |
| SCHEMBL27492278 | 1.00 | FDPS (0.45) | FDPSGGPS1CES2GAAPPARG | |
| SCHEMBL8376640 | 1.00 | FDPS (0.45) | FDPSGGPS1CES2GAAPPARG | |
| SCHEMBL3294519 | 1.00 | FDPS (0.45) | FDPSGGPS1CES2GAAPPARG | |
| SCHEMBL8376531 | 1.00 | FDPS (0.45) | FDPSGGPS1CES2GAAPPARG | |
| SCHEMBL9633625 | 1.00 | FDPS (0.45) | FDPSGGPS1CES2GAAPPARG | |
| SCHEMBL8377848 | 1.00 | FDPS (0.45) | FDPSGGPS1CES2GAAPPARG | |
| SCHEMBL380519 | 1.00 | FDPS (0.45) | FDPSGGPS1CES2GAAPPARG | |
| SCHEMBL3918719 | 1.00 | FDPS (0.45) | FDPSGGPS1CES2GAAPPARG | |
| SCHEMBL380743 | 0.98 | GAA (0.45) | FDPSGGPS1CES2GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282807-A1 | PROCESS FOR ISOLATION AND/OR PURIFYING OF GLYCOLIPIDS | AMPHISTAR (BE) | 2025-09-11 | — | — | US | claimed |
| EP-3692981-B1 | TOPICAL COMPOSITION FOR USE IN THE TREATMENT OF PSORIASIS | CHEM CURE ASS LLC (US) | 2022-05-04 | — | — | EP | claimed |
| EP-3305299-B1 | METHOD AND COMPOSITIONS FOR TREATING PSORIASIS | ANAPLASI PHARMACEUTICALS LLC (US) | 2020-04-29 | — | — | EP | claimed |
| EP-2363112-B1 | OSMOTIC DELIVERY SYSTEMS AND PISTON ASSEMBLIES | INTARCIA THERAPEUTICS INC (US) | 2018-10-10 | — | — | EP | claimed |
| EP-2906199-B1 | METHOD AND COMPOSITIONS FOR TREATING PSORIASIS | ANAPLASI PHARMACEUTICALS LLC (US) | 2018-01-03 | — | — | EP | claimed |
| EP-2285212-B1 | NOVEL PYRIPROXYFEN COMPOSITIONS | SUMITOMO CHEMICAL CO (JP) | 2016-02-17 | — | — | EP | claimed |
| EP-1814652-B1 | SURFACTANT SYSTEM METHOD | SURFACE ACTIVE SOLUTIONS HOLDINGS LTD (GB) | 2015-06-17 | — | — | EP | claimed |
| EP-0768817-B1 | EMULSIFIABLE CONCENTRATES CONTAINING ONE OR MORE PESTICIDES | HOECHST SCHERING AGREVO SA (FR) | 2000-03-15 | — | — | EP | claimed |
| US-20250282807-A1 | PROCESS FOR ISOLATION AND/OR PURIFYING OF GLYCOLIPIDS | AMPHISTAR (BE) | 2025-09-11 | — | — | US | disclosed |
| EP-4313350-A1 | PROCESS FOR ISOLATION AND/OR PURIFYING OF GLYCOLIPIDS | AMPHISTAR BV (BE) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022207086-A1 | PROCESS FOR ISOLATION AND/OR PURIFYING OF GLYCOLIPIDS | BIO BASE EUROPE PILOT PLANT VZW (BE) | 2022-10-06 | — | — | WO | disclosed |
| EP-3300795-B1 | A PROCESS FOR OBTAINING MICROCAPSULES | SIPCAM OXON S P A (IT) | 2021-06-30 | — | — | EP | disclosed |
| US-20200102255-A1 | NEW METHOD FOR FERTILIZING AGRICULTURAL SOIL | BASF CORPORATION | 2020-04-02 | — | — | US | disclosed |
| EP-2718411-B1 | SOPHOROLACTONE COMPOSITIONS AND USES THEREOF | ECOVER CO ORDINATION CENTER N V (BE) | 2019-09-11 | — | — | EP | disclosed |
| WO-2011029561-A2 | PESTICIDE PREPARATIONS | CLARIANT INTERNATIONAL LTD (CH) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011012493-A2 | PESTICIDAL SUSPO-EMULSION COMPOSITIONS | BASF SE (DE) | 2011-02-03 | — | — | WO | disclosed |
| WO-2010069848-A2 | AGROCHEMICAL FORMULATIONS CONTAINING PYRROLIDONE ALKYLENE OXIDES | BASF SE (DE) | 2010-06-24 | — | — | WO | disclosed |
| EP-2152843-A2 | MIXTURE COMPRISING AN ALKYL POLYGLUCOSIDE, A COSURFACTANT AND A POLYMER ADDITIVE | Bernd Schwegmann Gmbh&co. Kg (DE) | 2010-02-17 | — | — | EP | disclosed |
| WO-2008132202-A2 | MIXTURE COMPRISING AN ALKYL POLYGLUCOSIDE, A COSURFACTANT AND A POLYMER ADDITIVE | BERND SCHWEGMANN GMBH & CO. KG (DE) | 2008-11-06 | — | — | WO | disclosed |
| US-6468995-B1 | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282807-A1 | PROCESS FOR ISOLATION AND/OR PURIFYING OF GLYCOLIPIDS | MGLL, LIPA, LIPC | FDPS 660/4885GGPS1 104/4885CES2 539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.